Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Knorr, J. P.
Right arrow Articles by Sokoloski, M. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knorr, J. P.
Right arrow Articles by Sokoloski, M. C.
American Journal of Health-System Pharmacy, Vol. 65, Issue 6, 547-551
Copyright © 2008. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00


Case Report

Ciprofloxacin-induced Q-T interval prolongation

John P. Knorr, Mersedeh Moshfeghi and Mary C. Sokoloski

JOHN P. KNOR, PHARM.D., is Postgraduate Year One Pharmacy Resident, Albert Einstein Medical Center, Philadelphia, PA. MERSEDEH MOSHFEGHI, PHARM.D., is Clinical Coordinator, Pharmacy Department; and MARY C. SOKOLOSKI, M.D., is Pediatric Cardiologist, Cardiology Department, St. Christopher’s Hospital for Children, Philadelphia.

Address correspondence to Dr. Knorr at the Albert Einstein Medical Center, Department of Pharmacy, 5501 Old York Road, Philadelphia, PA 19141 (knorr.john{at}gmail.com).


Purpose. A case of Q-T interval prolongation in a pediatric patient with no known risk factors for the development of a long Q-T syndrome is reported.

Summary. A 16-year-old boy arrived at a children’s hospital reporting mucous diarrhea that had lasted two weeks, light-headedness with two blackouts on the day before his arrival to the hospital, and a 4.3-kg weight loss over the previous three weeks. He had a 3.5-year history of Crohn’s disease and had been hospitalized for two months with a diagnosis of colitis with cryptitis. He was admitted for the treatment of an acute flare of Crohn’s disease and a perirectal abscess. The patient was started on i.v. ciprofloxacin 400 mg twice daily and metronidazole 500 mg every six hours. The selected agents provided adequate empirical coverage of the suspected organisms and would not be contraindicated with the patient’s allergy to penicillin. Within 48 hours of administration of ciprofloxacin, the patient became bradycardic. The cardiology service was consulted, and an electrocardiogram showed a mildly prolonged Q-T interval (corrected Q-T interval, 486 msec) and low heart rate (42 beats/min). Antimicrobial therapy was changed to ampicillin and then to linezolid. The patient’s Q-T interval normalized within seven days of ciprofloxacin discontinuation. The patient had no further cardiac anomalies. Two weeks later, he was discharged on linezolid and aztreonam for the treatment of his abscess and was responding to treatment.

Conclusion. A pediatric patient with Crohn’s disease and colitis with cryptitis developed a prolonged Q-T interval within 48 hours of treatment with ciprofloxacin.

Index terms: Ciprofloxacin; Crohn disease; Long QT syndrome; Metronidazole; Pediatrics; Quinolones; Toxicity

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Health-System Pharmacists.